1. Home
  2. DUOL vs RGEN Comparison

DUOL vs RGEN Comparison

Compare DUOL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duolingo Inc.

DUOL

Duolingo Inc.

HOLD

Current Price

$118.94

Market Cap

8.4B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$141.49

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUOL
RGEN
Founded
2011
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
8.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DUOL
RGEN
Price
$118.94
$141.49
Analyst Decision
Buy
Buy
Analyst Count
17
11
Target Price
$270.00
$177.18
AVG Volume (30 Days)
2.6M
680.2K
Earning Date
02-26-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
338.81
N/A
EPS
8.04
0.03
Revenue
$964,271,000.00
$707,890,000.00
Revenue This Year
$40.64
$17.86
Revenue Next Year
$22.43
$12.44
P/E Ratio
$14.86
$4,604.96
Revenue Growth
39.86
11.74
52 Week Low
$112.41
$102.97
52 Week High
$544.93
$175.77

Technical Indicators

Market Signals
Indicator
DUOL
RGEN
Relative Strength Index (RSI) 20.55 30.69
Support Level $112.41 $138.52
Resistance Level $125.00 $160.88
Average True Range (ATR) 7.39 7.04
MACD -2.31 -2.48
Stochastic Oscillator 8.02 10.87

Price Performance

Historical Comparison
DUOL
RGEN

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: